MEDSTONE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDSTONE
Largest movements
- Cash +€151,089
up €151,089 (+129.8%), from €116,403 to €267,492
mainly Net result for the year (+€147,601) and Tax, wage and social debts (+€30,896)
- Deferred charges and accrued income +€10,628
up €10,628 (+16.2%), from €65,455 to €76,083
- Receivables within one year +€7,530
new in 2025: €7,530
- Profit (loss) carried forward +€147,601
up €147,601 (+130.9%), from €112,778 to €260,380
- Tax, wage and social debts +€30,896
up €30,896 (+79.9%), from €38,662 to €69,558
- Other debts -€21,178
no longer reported in 2025 (was €21,178)
- Trade debts +€10,233
up €10,233 (+233.6%), from €4,380 to €14,612
- Gross operating margin +€47,792
up €47,792 (+32.4%), from €147,281 to €195,073
- Taxes +€12,086
up €12,086 (+36.2%), from €33,414 to €45,500
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €186,998 | €354,957 | +€167,959 | +89.8% |
| Fixed assets | 21/28 | €5,140 | €3,853 | -€1,288 | -25.1% |
| Tangible fixed assets | 22/27 | €5,140 | €3,853 | -€1,288 | -25.1% |
| Furniture and vehicles | 24 | €5,140 | €3,853 | -€1,288 | -25.1% |
| Current assets | 29/58 | €181,858 | €351,105 | +€169,247 | +93.1% |
| Amounts receivable within one year | 40/41 | - | €7,530 | +€7,530 | |
| Other amounts receivable | 41 | - | €7,530 | +€7,530 | |
| Cash at bank and in hand | 54/58 | €116,403 | €267,492 | +€151,089 | +129.8% |
| Deferred charges and accrued income | 490/1 | €65,455 | €76,083 | +€10,628 | +16.2% |
| Total equity and liabilities | 10/49 | €186,998 | €354,957 | +€167,959 | +89.8% |
| Equity | 10/15 | €122,778 | €270,380 | +€147,601 | +120.2% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €112,778 | €260,380 | +€147,601 | +130.9% |
| Amounts payable | 17/49 | €64,219 | €84,578 | +€20,358 | +31.7% |
| Amounts payable within one year | 42/48 | €64,219 | €84,170 | +€19,950 | +31.1% |
| Trade debts | 44 | €4,380 | €14,612 | +€10,233 | +233.6% |
| Suppliers | 440/4 | €4,380 | €14,612 | +€10,233 | +233.6% |
| Taxes, remuneration and social security | 45 | €38,662 | €69,558 | +€30,896 | +79.9% |
| Taxes | 450/3 | €38,662 | €69,558 | +€30,896 | +79.9% |
| Other amounts payable | 47/48 | €21,178 | - | -€21,178 | |
| Accrued charges and deferred income | 492/3 | - | €408 | +€408 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €661 | €1,288 | +€627 | +94.9% |
| Other operating charges | 640/8 | €387 | €408 | +€20 | +5.3% |
| Gross operating margin | 9900 | €147,281 | €195,073 | +€47,792 | +32.4% |
| Operating profit (loss) | 9901 | €146,233 | €193,378 | +€47,145 | +32.2% |
| Financial charges | 65/66B | €41 | €277 | +€236 | +579.3% |
| Recurring financial charges | 65 | €41 | €277 | +€236 | +579.3% |
| Profit (loss) for the period before taxes | 9903 | €146,192 | €193,101 | +€46,909 | +32.1% |
| Income taxes | 67/77 | €33,414 | €45,500 | +€12,086 | +36.2% |
| Profit (loss) for the period | 9904 | €112,778 | €147,601 | +€34,823 | +30.9% |
| Profit (loss) for the period to be appropriated | 9905 | €112,778 | €147,601 | +€34,823 | +30.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.